Consensus statement: medical management of acromegaly

Eur J Endocrinol. 2005 Dec;153(6):737-40. doi: 10.1530/eje.1.02036.

Abstract

In November 2003, the Pituitary Society and the European Neuroendocrine Association sponsored a consensus workshop in Seville to address challenging issues in the medical management of acromegaly. Participants comprised 70 endocrinologists and neurosurgeons with international expertise in managing patients with acromegaly. All participants participated in the workshop proceedings, and the final document written by the scientific committee reflects the consensus opinion of the interactive deliberations. The meeting was supported by an unrestricted educational grant from Ipsen. No pharmaceutical representatives participated in the program planning or in the scientific deliberations.

Publication types

  • Consensus Development Conference
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acromegaly / drug therapy
  • Acromegaly / radiotherapy
  • Acromegaly / surgery
  • Acromegaly / therapy*
  • Dopamine Agonists / therapeutic use
  • Female
  • Human Growth Hormone / analogs & derivatives
  • Human Growth Hormone / blood
  • Human Growth Hormone / therapeutic use
  • Humans
  • Insulin-Like Growth Factor I / analysis
  • Male
  • Somatostatin / analogs & derivatives
  • Somatostatin / therapeutic use

Substances

  • Dopamine Agonists
  • Human Growth Hormone
  • Somatostatin
  • Insulin-Like Growth Factor I
  • pegvisomant